Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 17/20 | 0.87 |
| ▸ | CNR1 | P21554 | 11/20 | 0.87 |
| ▸ | TRPM8 | Q7Z2W7 | 3/20 | 0.87 |
| ▸ | LDHA | P00338 | 2/20 | 0.87 |
| ▸ | DAGLA | Q9Y4D2 | 2/20 | 0.87 |
| ▸ | PPARG | P37231 | 1/20 | 0.87 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.62 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.62 |
| ▸ | HTR1A | P08908 | 1/20 | 0.62 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.62 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.62 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.62 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.62 |
| ▸ | TRPV5 | Q9NQA5 | 1/20 | 0.62 |
| ▸ | TRPV2 | Q9Y5S1 | 1/20 | 0.62 |
| ▸ | ABHD12 | Q8N2K0 | 3/20 | 0.56 |
| ▸ | ABHD6 | Q9BV23 | 3/20 | 0.56 |
| ▸ | FAAH | O00519 | 2/20 | 0.56 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.56 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6856463 | 1.00 | CNR2 (0.87) | CNR2CNR1TRPM8LDHADAGLA | |
| SCHEMBL30325584 | 1.00 | CNR2 (0.87) | CNR2CNR1TRPM8LDHADAGLA | |
| SCHEMBL19422414 | 1.00 | CNR2 (0.87) | CNR2CNR1TRPM8LDHADAGLA | |
| SCHEMBL26487684 | 1.00 | CNR2 (0.87) | CNR2CNR1TRPM8LDHADAGLA | |
| SCHEMBL29784460 | 1.00 | CNR2 (0.87) | CNR2CNR1TRPM8LDHADAGLA | |
| SCHEMBL23210313 | 1.00 | CNR2 (0.87) | CNR2CNR1TRPM8LDHADAGLA | |
| SCHEMBL23765126 | 0.94 | CNR2 (0.94) | CNR2CNR1TRPM8LDHADAGLA | |
| SCHEMBL24704097 | 0.94 | CNR2 (0.94) | CNR2CNR1TRPM8LDHADAGLA | |
| SCHEMBL29647762 | 0.94 | CNR2 (0.94) | CNR2CNR1TRPM8LDHADAGLA | |
| SCHEMBL13214131 | 0.94 | CNR2 (0.94) | CNR2CNR1TRPM8LDHADAGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230125534-A1 | A Method to Produce Targeted Gene Editing Constructs | AGRICULTURE VICTORIA SERV PTY (AU) | 2023-04-27 | — | — | US | disclosed |
| US-20230125534-A1 | A Method to Produce Targeted Gene Editing Constructs | AGRICULTURE VICTORIA SERV PTY (AU) | 2023-04-27 | — | — | US | disclosed |
| US-11596618-B2 | Oral cannabinoid delivery formulations with mouthfeel experience enhancers | Resurgent Biosciences, Inc. (US) | 2023-03-07 | — | — | US | disclosed |
| US-20230027592-A1 | Method of Protein Extraction from Cannabis Plant Material | AGRICULTURE VICTORIA SERVICES PTY LTD (AU) | 2023-01-26 | — | — | US | disclosed |
| US-20230002838-A1 | Improved Methods for the Production of Plants | AGRICULTURE VICTORIA SERV PTY (AU) | 2023-01-05 | — | — | US | disclosed |
| US-20220387352-A1 | CANNABINOID COMPOSITIONS AND METHODS OF USING FOR THE TREATMENT OF NON-EOSINOPHILIC INFLAMMATION AND INFLAMMATORY DISORDERS | MEDTERRA PHARMA LLC | 2022-12-08 | — | — | US | disclosed |
| US-20220213428-A1 | APPARATUS, METHODS AND COMPOSITION FOR SYNTHESIS OF CANNABINOID COMPOUNDS | TEEWINOT LIFE SCIENCES CORPORATION (US) | 2022-07-07 | — | — | US | disclosed |
| US-20220187328-A1 | Methods of Terpene Profiling Cannabis Plant Material | AGRICULTURE VICTORIA SERVICES PTY LTD (AU) | 2022-06-16 | — | — | US | disclosed |
| US-20220051760-A1 | Method for Determining a Chemotypic Profile | AGRICULTURE VICTORIA SERVICES PTY LTD (AU) | 2022-02-17 | — | — | US | disclosed |
| US-20220000056-A1 | Cannabis Plants with a Cannabinoid Profile Enriched for Delta-9-Tetrahydrocannabinol, Cannabigerol and Tetrahydrocannabivarin | AGRICULTURE VICTORIA SERVICES PTY LTD (AU) | 2022-01-06 | — | — | US | disclosed |
| US-20210400895-A1 | Cannabis Plants with a Cannabinoid Profile Enriched for Delta-9-Tetrahydrocannabinol and Cannabigerol | AGRICULTURE VICTORIA SERVICES PTY LTD (AU) | 2021-12-30 | — | — | US | disclosed |
| US-20210400894-A1 | Plants with a Cannabinoid Profile Enriched for Cannabidiol | AGRICULTURE VICTORIA SERVICES PTY LTD (AU) | 2021-12-30 | — | — | US | disclosed |
| US-20210386031-A1 | Cannabis Plants with a Cannabinoid Profile Enriched for Cannabidiol and Delta-9-Tetrahydrocannabinol | AGRICULTURE VICTORIA SERVICES PTY LTD (AU) | 2021-12-16 | — | — | US | disclosed |
| WO-2020154772-A1 | METHODS OF TERPENE PROFILING CANNABIS PLANT MATERIAL. | AGRICULTURE VICTORIA SERVICES PTY LTD (AU) | 2020-08-06 | — | — | WO | disclosed |
| US-10336978-B2 | Apparatus, methods and composition for synthesis of cannabinoid compounds | TEEWINOT TECHNOLOGIES LIMITED (IE) | 2019-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220387352-A1 | CANNABINOID COMPOSITIONS AND METHODS OF USING FOR THE TREATMENT OF NON-EOSINOPHILIC INFLAMMATION AND INFLAMMATORY DISORDERS | CNR2, CNR1, FAAH2 | CNR2 1/4885CNR1 2/4885TRPM8 2198/4885 |
| US-11596618-B2 | Oral cannabinoid delivery formulations with mouthfeel experience enhancers | CNR2, CNR1, CPNE4 | CNR2 1/4885CNR1 2/4885TRPM8 46/4885 |
| US-20210400894-A1 | Plants with a Cannabinoid Profile Enriched for Cannabidiol | CNR2, CNR1, FAAH | CNR2 1/4885CNR1 2/4885TRPM8 1341/4885 |
| US-20220000056-A1 | Cannabis Plants with a Cannabinoid Profile Enriched for Delta-9-Tetrahydrocannabinol, Cannabigerol and Tetrahydrocannabivarin | CNR2, CNR1, CACNG8 | CNR2 1/4885CNR1 2/4885TRPM8 992/4885 |
| US-20210400895-A1 | Cannabis Plants with a Cannabinoid Profile Enriched for Delta-9-Tetrahydrocannabinol and Cannabigerol | CNR2, CNR1, DGKG | CNR2 1/4885CNR1 2/4885TRPM8 1587/4885 |
| US-20230027592-A1 | Method of Protein Extraction from Cannabis Plant Material | CNR2, CNR1, S100P | CNR2 1/4885CNR1 2/4885TRPM8 2701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.